Midas Pharma Japan

About Midas Pharma Japan

The affiliate was set up on April 1, 2011. It can look back on decades of pharmaceutical track-record (Director > 30 years with BI, Japan). For business into Japan: Midas services is a ‘vehicle’ to meet Japanese requirements, established standards, business culture and quality orientation. For business out of Japan: working with partners who have a unique product or technology that can be introduced to the Midas-Network for worldwide distribution. Customer / partner pool: access to the entire pharmaceutical industry, not only to customers, but also to local well established manufacturers with high reputation.

  • JP
  • 2015
    On CPhI since
Company types
Contract Service
Manufacturer/Innovator
Contact info
  • Absolute Yokohama Bashamichi Bldg 3F, 6-79 Ohta-Machi, Naka-ku, , 231-0011, Yokohama, Japan

Products from Midas Pharma Japan

  • Biotechnology services

    Product Biotechnology services

    Midas Pharma Japan offers wide range of pharmaceutical services which includes biotechnology services. It includes growth hormones, immunomodulators monoclonal antibodies, (anti) coagulation factors, customised enzymes for chemical synthesis, etc. It offers: dsp — purification, virus depletion, protein formulation (stabilization), gmp production, fill and finish, biosimilarity testing (full characterization of the reference product), etc.
  • Business development & licensing services

    Product Business development & licensing services

    Midas Pharma Japan offers wide range of pharmaceutical services which includes business development & licensing services. It includes commercialization strategy, promotion, search strategy and scouting, shortlisting and feasibility checking, negotiation, transaction support, etc.
  • Custom synthesis services

    Product Custom synthesis services

    Midas Pharma Japan offers wide range of pharmaceutical services which includes custom synthesis services. It can deliver one or all building blocks along your synthetic pathway including biocatalytic steps up to the final api. Offers: apis, high-potency apis (hapis), early and late stage/advanced intermediates (ims). It includes process development and optimization for apis and ims, up-scaling, process validation, development and validation of analytical methods, synthesis of impurities, reference standards, etc.